T1	Participants 407 475	Helicobacter pylori infected 10-21 year olds were offered treatment,
T2	Participants 578 778	Participants were randomized to either azithromycin 500 mg daily and tinidazole 500 mg two tablets daily in combination with lansoprasole 30 mg daily for 6 days (ATL-group) or with placebo (ATP-group)
T3	Participants 895 974	131 individuals were randomized, of whom 31 (24%) had undergone upper endoscopy
